These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 12497954)
21. [Care for the cardiopathy patient after percutaneous coronary intervention]. Barrera-Ramírez CF; Pineda Pompa LR; Guzmán CE Gac Med Mex; 2004; 140(6):619-27. PubMed ID: 15633569 [TBL] [Abstract][Full Text] [Related]
22. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients. Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692 [TBL] [Abstract][Full Text] [Related]
23. [The problem of preventing vascular restenosis after implantation of a coronary stent]. Sumarokov AB; Samko AN; Naumov VG Ter Arkh; 2004; 76(8):82-5. PubMed ID: 15471405 [No Abstract] [Full Text] [Related]
24. [Effects of percutaneous transluminal coronary angioplasty and stenting on QT dispersion in patients with coronary heart disease]. Zhang Y; Qi SS; Shen XQ; Zhou SH Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):171-2. PubMed ID: 12536661 [TBL] [Abstract][Full Text] [Related]
25. Endothelial progenitor cell (EPC) capture to aid vascular repair following coronary stenting: a new frontier in stent technology? Houtgraaf JH; Duckers HJ EuroIntervention; 2008 Aug; 4 Suppl C():C67-71. PubMed ID: 19202700 [No Abstract] [Full Text] [Related]
27. Oral rapamycin to prevent human coronary stent restenosis: a pilot study. Guarda E; Marchant E; Fajuri A; Martínez A; Morán S; Mendez M; Uriarte P; Valenzuela E; Lazen R Am Heart J; 2004 Aug; 148(2):e9. PubMed ID: 15309012 [TBL] [Abstract][Full Text] [Related]
28. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Steinberg DH; Mishra S; Javaid A; Slottow TL; Buch AN; Roy P; Okabe T; Smith KA; Torguson R; Xue Z; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R Am J Cardiol; 2007 Mar; 99(5):599-602. PubMed ID: 17317356 [TBL] [Abstract][Full Text] [Related]
29. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. Moses JW; Mehran R; Nikolsky E; Lasala JM; Corey W; Albin G; Hirsch C; Leon MB; Russell ME; Ellis SG; Stone GW J Am Coll Cardiol; 2005 Apr; 45(8):1165-71. PubMed ID: 15837244 [TBL] [Abstract][Full Text] [Related]
30. [Short and long-term therapeutic effects of rapamycin-eluting stent and paclitaxel-eluting stent in treatment of coronary disease with complicated lesions]. Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2183-6. PubMed ID: 16321180 [TBL] [Abstract][Full Text] [Related]
31. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255 [TBL] [Abstract][Full Text] [Related]
32. Polymeric stents: modern alchemy or the future? Murphy JG; Schwartz RS; Huber KC; Holmes DR J Invasive Cardiol; 1991; 3(3):144-8. PubMed ID: 10149123 [No Abstract] [Full Text] [Related]
33. Coronary artery bypass surgery or drug eluting stent for unprotected left main coronary artery disease. Gupta S; Gupta BM J Assoc Physicians India; 2007 Apr; 55():287-91. PubMed ID: 17694790 [TBL] [Abstract][Full Text] [Related]
35. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study. Tomai F; Reimers B; De Luca L; Galassi AR; Gaspardone A; Ghini AS; Ferrero V; Favero L; Gioffrè G; Prati F; Tamburino C; Ribichini F Diabetes Care; 2008 Jan; 31(1):15-9. PubMed ID: 17909090 [TBL] [Abstract][Full Text] [Related]
36. "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. Aoki J; Ong AT; Rodriguez Granillo GA; McFadden EP; van Mieghem CA; Valgimigli M; Tsuchida K; Sianos G; Regar E; de Jaegere PP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW Am Heart J; 2005 Nov; 150(5):994-9. PubMed ID: 16290984 [TBL] [Abstract][Full Text] [Related]
37. The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention. Dilmanian H; Aronow WS; Mundia M; Pucillo AL; Weiss MB; Kalapatapu K; Monsen CE Am J Ther; 2007; 14(3):277-9. PubMed ID: 17515704 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular stent design and vessel stresses: a finite element analysis. Lally C; Dolan F; Prendergast PJ J Biomech; 2005 Aug; 38(8):1574-81. PubMed ID: 15958213 [TBL] [Abstract][Full Text] [Related]
39. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Halkin A; Mehran R; Casey CW; Gordon P; Matthews R; Wilson BH; Leon MB; Russell ME; Ellis SG; Stone GW Am Heart J; 2005 Dec; 150(6):1163-70. PubMed ID: 16338253 [TBL] [Abstract][Full Text] [Related]
40. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study. Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]